	US 12,343,345 B2
	Non-infective nasal symptom management compositions and methods
Jay Richard Ray, II, Conroe, TX (US)
Assigned to CMPD Licensing, LLC, Conroe, TX (US)
Filed by CMPD LICENSING, LLC, Conroe, TX (US)
Filed on Aug. 30, 2021, as Appl. No. 17/460,693.
Application 17/460,693 is a continuation in part of application No. 16/167,108, filed on Oct. 22, 2018, granted, now 11,701,426.
Application 17/460,693 is a continuation in part of application No. 16/167,131, filed on Oct. 22, 2018.
Prior Publication US 2021/0386748 A1, Dec. 16, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/522 (2006.01); A61K 9/00 (2006.01); A61K 31/194 (2006.01); A61K 31/58 (2006.01); A61K 47/26 (2006.01)

CPC A61K 31/522 (2013.01) [A61K 9/0043 (2013.01); A61K 31/194 (2013.01); A61K 31/58 (2013.01); A61K 47/26 (2013.01)]

17 Claims

1. A method of formulating a topical composition comprising theophylline, sodium citrate, an aqueous diluent, and xylitol and/or poloxamers, wherein the method comprises combining:

theophylline in an amount between about 20 mg and about 200 mg,

sodium citrate in an amount between about 5 mg and about 150 mg, and

xylitol and/or poloxamers in an amount between about 50 mg and about 400 mg.